At the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, Antonio Pagliuca, MD from King’s College Hospital, London, UK gives an overview of the field of CAR T-cells. With both allogeneic and autologous CAR T-cells under development questions are being raised about their recommended uses and cost of development.